from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2090/-

LFCtreatmentdescriptionclass of inhibitor

-0.684

Amikacinug/mL Amikacintranslation

-0.413

Cap5-10ug/mL Capreomycintranslation

-0.210

Rox10-50 ug/mL Roxithromycintranslation

-0.852

SM2-5 ug/mL Streptomycintranslation

-0.132

Tet5-10 ug/mL Tetracyclinetranslation

0.497

Rif0.2-5ug/mL Rifampicintranscription

-0.198

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.024

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.441

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.178

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.280

Clofazimine10-13 ug/mL Clofaziminerespiration

0.165

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.262

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.818

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.073

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.306

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.171

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.450

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.257

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.360

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.249

KCN5-20 ug/mL Potassium cyaniderespiration

1.764

NaN30.2-2 mM Sodium aziderespiration

0.396

Nigericin50 uM Nigericinrespiration

0.152

TRC10-150 ug/mL Triclosanrespiration

-1.556

TRZ10-25 ug/mL Thioridazinerespiration

-1.577

Valinomycin0.5-10 uM Valinomycinrespiration

-1.292

ZnSO42 mM ZnSO4respiration

-0.224

menadione6-10 ug/mL Menadionerespiration

-0.647

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.452

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.585

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.305

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.805

NRP_1Non-replicating persistence stage 1dosRassociated

0.458

Amp0.2mg/mL AmpicillincellWall

0.554

Cephalexin20-100 ug/mL CephalexincellWall

0.044

Cerulenin0.32-5 ug/mL CerulenincellWall

0.160

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.247

EMB10-20 ug/mL EthambutolcellWall

0.512

Eta12-40 ug/mL EthionamidecellWall

-0.068

INH0.2-0.4 ug/mL IsoniazidcellWall

0.179

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.814

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.332

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.045

BZA0.12 mg/mL BenzamidearomaticAmides

0.212

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.158

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.240

H2O24 mM hydrogen peroxideDNAdamaging

-0.154

Levo10 ug/mL LevofloxacinDNAdamaging

0.357

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.203

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.079

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.060

UVUV-irradiationDNAdamaging

-0.361

ARP41-4 ug/mL Antitubercular compound ARP4?

0.115

Antimycin12.5-50 ug/mL Antimycin A?

-0.139

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.021

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.232

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.180

PA8240.2-2 ug/mL PA-824?

-0.390

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.245

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.304

Verapamil50 uM Verapamil?

0.719

mercaptoethanol2 mM 2-Mercaptoethanol?

0.323

methoxatin10-20 ug/mL Methoxatin?